Letermovir

  • BIGBEAR Pharmaceutical announces the approval of Letermovir in Laos

    Vientiane, Laos - September 20, 2024 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer treatments, today announced that 2 products have been approved by the Ministry of Health of Laos. Approved drugs are: Letermovir: sold under the brand name LETEDX.Letermovir is an antiviral drug…


Top